📰 Sun Young Rha News
Sun Young Rha News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sun Young Rha. Real-time updates on events, politics, business and more.
June 28, 2023
Adding anti-HER2 agent to ramucirumab, paclitaxel exceeds historical PFS with doublet
April 13, 2023
The FDA has accepted for review a supplemental biologics license application for pembrolizumab plus fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.
March 7, 2023
Adding pembrolizumab to frontline chemotherapy improves outcomes in patients with HER2-, advanced gastric or GEJ cancers, a phase 3 trial suggests.
February 28, 2023
Adding pembrolizumab to frontline chemotherapy improves outcomes in patients with HER2-, advanced gastric or GEJ cancers, a phase 3 trial suggests.
January 13, 2022
/PRNewswire/ --Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce an extension of the option agreement...
January 13, 2022
/PRNewswire/ --Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce an extension of the option agreement...